A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma

Clinical trial NCT03181126 · COMPLETED

Trial details

NCT number: NCT03181126
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL)Lymphoblastic Lymphoma

Start date: 2017-11-27
Primary completion: 2020-11-11
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.